TheRightDoctors Logo
Pre Alpha
Insights from the world's best medical minds
nine

Dr. Tiny Nair : New Thrombolytic Agents Better Than The Older Options

Tenecteplase has many advantages over streptokinase, but is also ten times pricier.
Dr. Tiny Nair Leading Cardiologist and Head Department of Cardiology PRS hospital, Trivandrum An overview on The Right Thrombolytic Agent for Indian Aam Aadmi
Pause
Love It
Embed

Supported by an Unrestricted
Educational Grant from

Sanofi Logo

Dr. Tiny Nair

Chief Consultant Cardiologist

PRS Hospital, Kerala


“Tenecteplase, a new thrombolytic agent is fibrin specific and has ease of administration, but it is ten times pricier than the old streptokinase, which is not fibrin specific but cheap and easily available,” Dr. Tiny Nair tells Dr. Rishi Jain in an interview. But if this one-time cost gives better left ventricular function and a better quality life, then the advantages of tenecteplase over streptokinase are worth it- better patency rate, more TIMI 2 and 3 flow and quick action. “Tenecteplase would be definitely preferred over streptokinase if cost factor is eliminated. Therefore, our aim should be to buffer the cost difference between the two.”Dr. Nair also recommends thrombolysis in cases where door-to-balloon time exceeds 90 minutes.


Mail us at editorial@therightdoctors.com. Stay updated on Facebook , Twitter , You Tube and LinkedIn.

Join TheRightDoctors on WhatsApp. Type "JOIN" and send to 9676401536

Iron deficiency and iron deficiency anemia

Dr. Jabir Abdullakutty

Pause
Love It
Embed

Dr. Jabir Abdullakutty

Consultant Cardiologist

Lisie Hospital, Kerala



Join TheRightDoctors on WhatsApp. Type "JOIN" and send to 9676401536